MLP Health Financials and Target Price Gap: Record 728.5 TL

MLP Health Services delivered a surprise performance in the first half of 2026, boosting net profit by 4.47%.

Financial Highlights of H1 2026

■Net period profit: 3,153,018,000 TRY, up from 3,018,030,000 TRY a year earlier.

■Annual net profit increase: 134,988,000 TRY.

■Q2 net profit: 1.37 billion TRY, surpassing the median forecast of 1.12 billion TRY.

Target Price Divergence and Market Sentiment

■Lowest target: 608.00 TRY (Kuveyt Türk Investment).

■Highest target: 728.50 TRY (Fiba Investment).

■Price spread: 120.50 TRY (~19.82%).

Technical Landscape and Index Impact

■Fibonacci retracement: The upper target lies near a 19.8% resistance zone.

■Ichimoku cloud: Current price approaching the cloud’s upper edge, indicating strengthening upward momentum.

■50‑day and 200‑day moving averages: Short‑term average above the long‑term average, supporting a bullish bias.

Strategic Recommendation and Risk Framework

■Buy opportunity: Wide target spread favors investors comfortable with volatility.

■Cautionary notes: The broad price range signals market uncertainty; prudent positioning is advised.

■Position sizing: Limit exposure to no more than 5% of the portfolio to maintain risk discipline.

Caner Yılmaz: “The quarter results reflect a sector‑wide recovery, but the expansive target range calls for a measured approach. While technical indicators point bullish, entering below the Fibonacci resistance offers a lower‑risk entry point.”